SGRY · Surgery Partners, Inc.
$15.73
+2.70% last session
End-of-day data · updated 2026-07-28
Market cap
$2B
Enterprise value
$8B
Trailing P/E
—
Forward P/E
22.7
Dividend yield
—
Beta
1.89
Avg volume
1M
Employees
16K
2D change
—
5D change
-0.33%
10D change
-5.13%
30D change
-4.11%
60D change
13.55%
MTD change
-8.61%
YTD change
-1.81%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SGRY
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-03-05
Latest call per bank · past 12 months
UBS
Buy$21.00
+33.5% vs priceRBC Capital
Outperform$20.00
+27.1% vs priceBarclays
Equal-Weight$14.00
-11.0% vs priceJP Morgan
Neutral$20.00
+27.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-03-05 | TD Cowen | Maintains | Buy | $28.00 → $20.00 |
| 2026-03-05 | UBS | Maintains | Buy | $29.00 → $21.00 |
| 2026-03-05 | Mizuho | Maintains | Outperform | $19.00 → $17.00 |
| 2026-03-04 | RBC Capital | Maintains | Outperform | $31.00 → $20.00 |
| 2026-03-03 | Barclays | Maintains | Equal-Weight | $18.00 → $14.00 |
| 2025-12-18 | Mizuho | Maintains | Outperform | $22.00 → $19.00 |
| 2025-11-24 | JP Morgan | Maintains | Neutral | $27.00 → $20.00 |
| 2025-11-21 | Barclays | Maintains | Equal-Weight | $24.00 → $18.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 49 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 4.0% above the 50-day MA ($14.98).
- Price vs 200-day MA: Trading 0.3% above the 200-day MA ($15.54).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-0.19) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($11.49) and high ($23.84).
SGRY Price Chart
Loading chart for SGRY…
Fundamentals
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.